Evidence map›Paper›PMID 15767368›Full record

ArticleThe Journal of experimental medicine2005

Regulation of anaphylactic responses by phosphatidylinositol phosphate kinase type I {alpha}.

Junko Sasaki, Takehiko Sasaki, Masakazu Yamazaki, Kunie Matsuoka, Choji Taya, Hiroshi Shitara, Shunsuke Takasuga, Miki Nishio, Katsunori Mizuno, Teiji Wada and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The multifaceted role of PIP2 in leukocyte biology.Cellular and molecular life sciences : CMLS · 2015
    Review
  5. Article
  6. Review
  7. The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  8. Review
  9. Article
  10. Phosphatidylinositol 4,5-bisphosphate: targeted production and signaling.BioEssays : news and reviews in molecular, cellular and developmental biology · 2013
    Review
  11. Critical roles of type III phosphatidylinositol phosphate kinase in murine embryonic visceral endoderm and adult intestine.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  12. Article
  13. Reduced phosphatidylinositol 4,5-bisphosphate synthesis impairs inner ear Ca2+ signaling and high-frequency hearing acquisition.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 5 institutions in 3 countries.

Junko SasakiDepartment of Pharmacology, Tokyo Metropolitan Institute of Medical Science, Tokyo 113-8613, Japan.
Takehiko Sasaki
Masakazu Yamazaki
Kunie Matsuoka
Choji Taya
Hiroshi Shitara
Shunsuke Takasuga
Miki Nishio
Katsunori Mizuno
Teiji Wada
Hideyuki Miyazaki
Hiroshi Watanabe
Ryota Iizuka
Shuichi Kubo
Shigeo Murata
Tomoki Chiba
Tomohiko Maehama
Koichi Hamada
Hiroyuki Kishimoto
Michael A Frohman
Keiji Tanaka
Josef M Penninger
Hiromichi Yonekawa
Akira Suzuki
Yasunori Kanaho
Tokyo Metropolitan Institute of Medical Science · JPAkita University · JPAustrian Academy of Sciences · ATJapan Science and Technology Agency · JPState University of New York · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The membrane phospholipid phosphatidylinositol 4, 5-bisphosphate [PI(4,5)P(2)] is a critical signal transducer in eukaryotic cells. However, the physiological roles of the type I phosphatidylinositol phosphate kinases (PIPKIs) that synthesize PI(4,5)P(2) are largely unknown. Here, we show that the alpha isozyme of PIPKI (PIPKIalpha) negatively regulates mast cell functions and anaphylactic responses. In vitro, PIPKIalpha-deficient mast cells exhibited increased degranulation and cytokine production after Fcepsilon receptor-I cross-linking. In vivo, PIPKIalpha(-/-) mice displayed enhanced passive cutaneous and systemic anaphylaxis. Filamentous actin was diminished in PIPKIalpha(-/-) mast cells, and enhanced degranulation observed in the absence of PIPKIalpha was also seen in wild-type mast cells treated with latrunculin, a pharmacological inhibitor of actin polymerization. Moreover, the association of FcepsilonRI with lipid rafts and FcepsilonRI-mediated activation of signaling proteins was augmented in PIPKIalpha(-/-) mast cells. Thus, PIPKIalpha is a negative regulator of FcepsilonRI-mediated cellular responses and anaphylaxis, which functions by controlling the actin cytoskeleton and dynamics of FcepsilonRI signaling. Our results indicate that the different PIPKI isoforms might be functionally specialized.

Indexed as

ActinsAnaphylaxisAnimalsCalcium SignalingCell DegranulationCells, CulturedIsoenzymesMast CellsMembrane MicrodomainsMiceMice, KnockoutMinor Histocompatibility AntigensPhosphatidylinositol 4,5-DiphosphatePhosphotransferases (Alcohol Group Acceptor)Receptors, IgEThiazolesActinsIsoenzymesMinor Histocompatibility AntigensPhosphatidylinositol 4,5-Diphosphatephosphatidylinositol phosphate 4-kinasePhosphotransferases (Alcohol Group Acceptor)Receptors, IgEThiazoles

Identifiers

PMID15767368
PMCPMC2213097
OpenAlexW2106894798

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.